These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 33016928)

  • 1. Multiomic analysis and immunoprofiling reveal distinct subtypes of human angiosarcoma.
    Chan JY; Lim JQ; Yeong J; Ravi V; Guan P; Boot A; Tay TKY; Selvarajan S; Md Nasir ND; Loh JH; Ong CK; Huang D; Tan J; Li Z; Ng CC; Tan TT; Masuzawa M; Sung KW; Farid M; Quek RHH; Tan NC; Teo MCC; Rozen SG; Tan P; Futreal A; Teh BT; Soo KC
    J Clin Invest; 2020 Nov; 130(11):5833-5846. PubMed ID: 33016928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical, genomic, and transcriptomic correlates of response to immune checkpoint blockade-based therapy in a cohort of patients with angiosarcoma treated at a single center.
    Rosenbaum E; Antonescu CR; Smith S; Bradic M; Kashani D; Richards AL; Donoghue M; Kelly CM; Nacev B; Chan JE; Chi P; Dickson MA; Keohan ML; Gounder MM; Movva S; Avutu V; Thornton K; Zehir A; Bowman AS; Singer S; Tap W; D'Angelo S
    J Immunother Cancer; 2022 Apr; 10(4):. PubMed ID: 35365586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-Throughput Transcriptomics Identifies Chemoresistance-Associated Gene Expression Signatures in Human Angiosarcoma.
    Khor GMS; Haghani S; Tan TRE; Lee ECY; Kannan B; Lim BY; Lee JY; Guo Z; Ko TK; Chan JY
    Int J Mol Sci; 2024 Oct; 25(19):. PubMed ID: 39409192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spatial transcriptomics reveal topological immune landscapes of Asian head and neck angiosarcoma.
    Loh JW; Lee JY; Lim AH; Guan P; Lim BY; Kannan B; Lee ECY; Gu NX; Ko TK; Ng CC; Lim JCT; Yeong J; Lim JQ; Ong CK; Teh BT; Chan JY
    Commun Biol; 2023 Apr; 6(1):461. PubMed ID: 37106027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA Methylation Profiling Identifies Distinct Clusters in Angiosarcomas.
    Weidema ME; van de Geer E; Koelsche C; Desar IME; Kemmeren P; Hillebrandt-Roeffen MHS; Ho VKY; van der Graaf WTA; Versleijen-Jonkers YMH; von Deimling A; Flucke UE;
    Clin Cancer Res; 2020 Jan; 26(1):93-100. PubMed ID: 31562204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiosarcoma heterogeneity and potential therapeutic vulnerability to immune checkpoint blockade: insights from genomic sequencing.
    Boichard A; Wagner MJ; Kurzrock R
    Genome Med; 2020 Jul; 12(1):61. PubMed ID: 32646514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor Microenvironment and Its Clinicopathologic and Prognostic Association in Cutaneous and Noncutaneous Angiosarcomas.
    Machado I; Requena C; López-Reig R; Fernández-Serra A; Giner F; Cruz J; Traves V; Lavernia J; Claramunt R; Llombart B; López-Guerrero JA; Llombart-Bosch A
    Am J Clin Pathol; 2023 Jul; 160(1):18-34. PubMed ID: 36893014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM pan-cancer cohort.
    Damotte D; Warren S; Arrondeau J; Boudou-Rouquette P; Mansuet-Lupo A; Biton J; Ouakrim H; Alifano M; Gervais C; Bellesoeur A; Kramkimel N; Tlemsani C; Burroni B; Duche A; Letourneur F; Si H; Halpin R; Creasy T; Herbst R; Ren X; Morel P; Cesano A; Goldwasser F; Leroy K
    J Transl Med; 2019 Nov; 17(1):357. PubMed ID: 31684954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis.
    Yu Y; Zeng D; Ou Q; Liu S; Li A; Chen Y; Lin D; Gao Q; Zhou H; Liao W; Yao H
    JAMA Netw Open; 2019 Jul; 2(7):e196879. PubMed ID: 31290993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted massively parallel sequencing of angiosarcomas reveals frequent activation of the mitogen activated protein kinase pathway.
    Murali R; Chandramohan R; Möller I; Scholz SL; Berger M; Huberman K; Viale A; Pirun M; Socci ND; Bouvier N; Bauer S; Artl M; Schilling B; Schimming T; Sucker A; Schwindenhammer B; Grabellus F; Speicher MR; Schaller J; Hillen U; Schadendorf D; Mentzel T; Cheng DT; Wiesner T; Griewank KG
    Oncotarget; 2015 Nov; 6(34):36041-52. PubMed ID: 26440310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aristolochic acid-related renal cell carcinoma exhibits a distinct tumor-immune microenvironment favoring response to immune checkpoint blockade.
    Lin PH; Chan JY; Guan P; Hong JH; Lim AH; Ng CC; Yeong JPS; Lee JY; Liu W; Lim JCT; Pang ST; Teh BT
    J Pathol; 2024 Dec; 264(4):371-382. PubMed ID: 39360336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-Infiltrating Mast Cells in Angiosarcoma Correlate With Immuno-Oncology Pathways and Adverse Clinical Outcomes.
    Tai SB; Lee ECY; Lim BY; Kannan B; Lee JY; Guo Z; Ko TK; Ng CC; Teh BT; Chan JY
    Lab Invest; 2024 Mar; 104(3):100323. PubMed ID: 38218317
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Xie HM; Bernt KM
    Biomolecules; 2022 Aug; 12(8):. PubMed ID: 36009018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Genomic Landscape of Merkel Cell Carcinoma and Clinicogenomic Biomarkers of Response to Immune Checkpoint Inhibitor Therapy.
    Knepper TC; Montesion M; Russell JS; Sokol ES; Frampton GM; Miller VA; Albacker LA; McLeod HL; Eroglu Z; Khushalani NI; Sondak VK; Messina JL; Schell MJ; DeCaprio JA; Tsai KY; Brohl AS
    Clin Cancer Res; 2019 Oct; 25(19):5961-5971. PubMed ID: 31399473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implications of systemic and local immune responses in human angiosarcoma.
    Chan JY; Tan GF; Yeong J; Ong CW; Ng DYX; Lee E; Koh J; Ng CC; Lee JY; Liu W; Wong RX; Ong CJ; Farid M; Teh BT; Soo KC
    NPJ Precis Oncol; 2021 Feb; 5(1):11. PubMed ID: 33580206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frameshift events predict anti-PD-1/L1 response in head and neck cancer.
    Hanna GJ; Lizotte P; Cavanaugh M; Kuo FC; Shivdasani P; Frieden A; Chau NG; Schoenfeld JD; Lorch JH; Uppaluri R; MacConaill LE; Haddad RI
    JCI Insight; 2018 Feb; 3(4):. PubMed ID: 29467336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral and salivary gland angiosarcoma: a clinicopathologic study of 29 cases.
    Fanburg-Smith JC; Furlong MA; Childers EL
    Mod Pathol; 2003 Mar; 16(3):263-71. PubMed ID: 12640107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Key roles for MYC, KIT and RET signaling in secondary angiosarcomas.
    Styring E; Seinen J; Dominguez-Valentin M; Domanski HA; Jönsson M; von Steyern FV; Hoekstra HJ; Suurmeijer AJ; Nilbert M
    Br J Cancer; 2014 Jul; 111(2):407-12. PubMed ID: 24983371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interference of tumour mutational burden with outcome of patients with head and neck cancer treated with definitive chemoradiation: a multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group.
    Eder T; Hess AK; Konschak R; Stromberger C; Jöhrens K; Fleischer V; Hummel M; Balermpas P; von der Grün J; Linge A; Lohaus F; Krause M; Baumann M; Stuschke M; Zips D; Grosu AL; Abdollahi A; Debus J; Belka C; Pigorsch S; Combs SE; Budach V; Tinhofer I;
    Eur J Cancer; 2019 Jul; 116():67-76. PubMed ID: 31173964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative lengthening of telomeres phenotype in malignant vascular tumors is highly associated with loss of ATRX expression and is frequently observed in hepatic angiosarcomas.
    Liau JY; Tsai JH; Yang CY; Lee JC; Liang CW; Hsu HH; Jeng YM
    Hum Pathol; 2015 Sep; 46(9):1360-6. PubMed ID: 26190196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.